Amuran

Amuran150 mg

Ranitidine

Amulet Pharmaceuticals Ltd.

Product Code : 931
MRP 2.00
10% Off
Best PriceTk
/
Out Of Stock
1
Section

Alternatives

See All
Product Image
10% Off

Gastab150 mg

Ranitidine

NIPRO JMI Pharma Ltd.

1.81
2.01
Out Of Stock
Product Image
10% Off

Neoceptin R150 mg

Ranitidine

Beximco Pharmaceuticals Ltd.

2.70
3.00
Out Of Stock
Product Image
10% Off

Ranidin150 mg

Ranitidine

ACME Laboratories Ltd.

2.70
3.00
Out Of Stock
Product Image
10% Off

Acin150 mg

Ranitidine

Biopharma Laboratories Ltd.

1.82
2.02
Out Of Stock
Product Image
8% Off

Asinar150 mg

Ranitidine

Synovia Pharma PLC

2.31
2.51
Add to cart
Product Image
10% Off

Eucon150 mg

Ranitidine

Pacific Pharmaceuticals Ltd.

1.71
1.90
Out Of Stock
Product Image
10% Off

G-Ranitidin150 mg

Ranitidine

Gonoshasthaya Pharma Ltd.

1.34
1.49
Out Of Stock
Product Image
10% Off

Gastroloc150 mg

Ranitidine

Beacon Pharmaceuticals Ltd.

1.80
2.00
Out Of Stock
Product Image
10% Off

Gepin150 mg

Ranitidine

General Pharmaceuticals Ltd.

1.81
2.01
Add to cart
Product Image
10% Off

Inseac150 mg

Ranitidine

Ibn-Sina Pharmaceuticals Ltd.

2.24
2.49
Out Of Stock
Product Image
10% Off

Neofast-S150 mg

Ranitidine

Incepta Pharmaceuticals Ltd.

1.80
2.00
Out Of Stock
Product Image
10% Off

Neotack150 mg

Ranitidine

Square Pharmaceuticals Ltd.

2.70
3.00
Out Of Stock
Product Image
10% Off

Norma-H150 mg

Ranitidine

Renata Limited

2.25
2.50
Out Of Stock
Product Image
10% Off

Ortac150 mg

Ranitidine

Orion Pharma Ltd.

1.81
2.01
Add to cart
Product Image
10% Off

Peptil H150 mg

Ranitidine

Eskayef Bangladesh Ltd.

1.80
2.00
Add to cart
Product Image
10% Off

Ranid150 mg

Ranitidine

Ziska Pharmaceuticals Ltd.

1.21
1.34
Add to cart
Product Image
10% Off

Ranison150 mg

Ranitidine

Jayson Pharma Ltd.

1.56
1.73
Out Of Stock
Product Image
10% Off

Ranitid150 mg

Ranitidine

Opsonin Pharma Ltd.

2.70
3.00
Add to cart
Product Image
10% Off

Ranitor150 mg

Ranitidine

Popular Pharmaceuticals Ltd.

1.80
2.00
Add to cart
Product Image
10% Off

Ravia150 mg

Ranitidine

Pharmasia Limited

0.90
1.00
Out Of Stock
Product Image
10% Off

Reetac-R150 mg

Ranitidine

Navana Pharmaceuticals Ltd.

1.80
2.00
Out Of Stock
Product Image
10% Off

Resectin150 mg

Ranitidine

Social Marketing Company

2.25
2.50
Add to cart
Product Image
10% Off

Rhine150 mg

Ranitidine

Healthcare Pharmacuticals Ltd.

2.70
3.00
Out Of Stock
Product Image
10% Off

Tinadin150 mg

Ranitidine

Delta Pharma Ltd.

1.35
1.50
Out Of Stock
Product Image
10% Off

Ulcar150 mg

Ranitidine

Drug International Ltd.

2.29
2.55
Add to cart
Product Image
10% Off

Ultradin150 mg

Ranitidine

Globe Pharmaceuticals Ltd.

2.25
2.50
Out Of Stock
Product Image
10% Off

Wintack150 mg

Ranitidine

The White Horse Pharma

1.80
2.00
Out Of Stock
Product Image
10% Off

Xantid150 mg

Ranitidine

ACI Limited

2.26
2.51
Out Of Stock
Section

Medicine overview

Indications of Amuran 150 mg

Amuran 150 mg is indicated in: Treatment of active duodenal ulcer Benign gastric ulcer Treatment & prevention of ulcer associated with non-steroidal anti-inflammatory agent Post operative stress ulcer. Zollinger-Ellison Syndrome. Gastroesophageal reflux disease (GERD). Gastro-intestinal haemorrhage from stress ulcer in seriously ill patient. Recurrent haemorrhage in patients with bleeding peptic ulcer. Before general anesthesia in patient considered to be at risk of acid aspiration particulary obstetric patients.

Theropeutic Class

H2 receptor antagonist

Pharmacology

Amuran 150 mg competitively blocks histamine at H2-receptors of the gastric parietal cells which inhibits gastric acid secretion. It does not affect pepsin secretion, pentagastrin-stimulated intrinsic factor secretion or serum gastrin.

Dosage & Administration of Amuran 150 mg

Amuran 150 mg Tablet & Syrup: Duodenal and gastric ulcer: The usual dosage is 150 mg twice daily taken in the morning and evening or 300 mg as a single daily dose at night for 4 to 8 weeks.Reflux oesophagitis: 150 mg twice daily or 300 mg at bed time for up to 8 weeks.Zollinger Ellison syndrome: 150 mg 3 times daily and increased if necessary up to 6 g daily in divided doses. Dosage should be continued as long as clinically indicated.Episodic dyspepsia: 150 mg twice daily or 300 mg at bed time for up to 6 weeks.Maintenance: 150 mg at night for preventing recurrences.Child (peptic ulcer): 2-4 mg/kg twice daily, maximum 300 mg daily. Amuran 150 mg IV injection & IV Infusion: Amuran 150 mg injection may be given either as a slow (over a period of at least two minutes) intravenous injection of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every six to eight hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at six to eight hour intervals; or as an intramuscular injection of 50 mg (2 ml) every six to eight hours. In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences.In the prophylaxis of upper gastrointestinal haemorrhage from stress ulceration in seriously ill patient sapriming dose of 50 mg as low as intravenous injection followed by a continuous intravenous infusion of 0.125-0.250 mg/kg/hour may be preferred. In patients considered to be at risk of developing aspiration syndrome Amuran 150 mg injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.Children: The recommended oral dose for the treatment of peptic ulcer in children is 2 mg/kg to 4 mg/kg twice daily to a maximum of 300 mg Amuran 150 mg per day. Safety and effectiveness of Amuran 150 mg injection have not been established in case of children.

Interaction of Amuran 150 mg

Delayed absorption and increased peak serum concentration with propantheline bromide. Amuran 150 mg minimally inhibits hepatic metabolism of coumarin anticoagulants, theophylline, diazepam and propanolol. May alter absorption of pH-dependent drugs (e.g. ketoconazole, midazolam, glipizide). May reduce bioavailability with antacids.

Contraindications

Patients hypersensitive to Amuran 150 mg

Side Effects of Amuran 150 mg

Amuran 150 mg is well tolerated and side effects are usually uncommon. Altered bowel habit, dizziness, rash, tiredness, reversible confusional states, headache, decreased blood counts, muscle or joint pain have rarely been reported.

Pregnancy & Lactation

Pregnancy: Amuran 150 mg crosses the placenta. But there is no evidence of impaired fertility or harm to the foetus due to Amuran 150 mg. Like other drugs, Amuran 150 mg should only be used during pregnancy if considered essential.Lactation: Amuran 150 mg is excreted in human breast milk. Caution should be exercised when the drug is administered to a nursing mother.

Precautions & Warnings

Amuran 150 mg should be given in reduced dosage to patients with impaired renal and hepatic function.

Overdose Effects of Amuran 150 mg

Amuran 150 mg is very specific in action and accordingly no particular problems are expected following overdosage with the drug. Symptomatic and supportive therapy should be given as appropriate. If required, the drug may be removed from the plasma by haemodiaiysis.

Storage Conditions

Store in a cool and dry place. protect from light.

Use In Special Populations

Use in elderly patients: In clinical trial the ulcer healing rates have been found similar in patients age 65 and over with those in younger patients. Additionally, there was no difference in the incidence of adverse effects.

Reconstitution

Slow IV inj: Amuran 150 mg 50 mg diluted to a concentration ≤2.5 mg/mL (e.g. total of 20 mL) with NaCl 0.9% inj or dextrose 5% or 10%, lactated Ringer's, Na bicarbonate 5% soln. Intermittent slow IV infusion: Amuran 150 mg 50 mg diluted to a concentration ≤0.5 mg/mL (e.g. total of 100 mL) of dextrose 5% inj or NaCl 0.9%, lactated Ringer's, Na bicarbonate 5% soln. Continuous IV infusion: Amuran 150 mg 150 mg diluted in 250 mL of dextrose 5% inj or NaCl 0.9%, lactated Ringer's, Na bicarbonate 5% soln. Patients with Zollinger-Ellison syndrome or other hypersecretory conditions: Amuran 150 mg should be diluted to a concentration ≤2.5 mg/mL with dextrose 5% or NaCl 0.9%, lactated Ringer's, Na bicarbonate 5% soln.
Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.